Summary

The regulation of similar biotherapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Colombia, Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market.

Biosimilars Latam – Colombia 2020 Forum is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market.

Join us in Colombia and trigger a quantum leap in Latin American Healthcare!

Who will
you meet?

 

More than:

Participants

Companies

HCPs

Patients

Academy

Investors

Institutions

Associations

Service Providers

Government Agencies

Industry Executives from Latam

From these areas:

  • Biosimilars
  • Biobetters
  • Biotechnology
  • Biotherapeutics
  • Analytical science
  • Regulatory compliance
  • Quality Control
  • Clinical immunology
  • Scientific Affairs
  • Pharmacovigilance
  • Research
  • Regulatory
  • Business Development
  • Marketing

Speakers

Latam Biosimilars’s Insight. Panel Industry Leaders

Edgar Mauricio Rubio
Indukern, Colombia
Pharmaceutical & Animal Health Division Manager

Eduardo Cioppi
mAbxience, Argentina
Regional Director – Latin America

Jaime Uribe
PROBIOMED, Mexico
CEO

Perception on Biosimilars from Local Patients and HCPs. Panel
Nancy Huertas
Keralty, Colombia
Global Director of Pharmaceutical Affairs

Jorge García
BIOREDCOL, Colombia
President

Pharmacovigilance in Latam
Claudia Patricia Vaca
Think Tank “Medicines, Information and Power” UNAL, Colombia
Founder and Head
Current Technology used in Latam for Biosimilars Development. Panel
Claudia Marcela Betancour
Biointropic, Colombia
Executive Director

Oscar Gamiz Vargas
BD, Mexico
Marketing Head PS Latam

International Standard for the Evaluation and Approval of Biologics/Biosimilars. Panel
Carolina Gomez
Think Tank “Medicines, Information and Power” UNAL, Colombia
Founder and Researcher

Jose Josan
Universidad Peruana Cayetano Heredia, Peru
Professor

What the Future of Biosimilars in Colombia is? Panel
Nidia Delgado
National Cancer Institute, Colombia
Instructor
Full programme in the PDF Agenda
Download

Sponsors

BioMérieux

The production of biologic-based pharmaceuticals is long and complex. Rapid answers from in-process controls confirm your production process is operating as designed—efficiently confirming product quality. With the most comprehensive portfolio of microbiology solutions for bioproduction, bioMérieux helps protect your customers, keep you in compliance, and improve your bottom line.

Becton Dickinson and Company

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories.

Terumo

We develop alliances with pharmaceutical companies, using Terumo technology to develop, manufacture and supply solutions to injectable drug delivery challenges. We pride ourselves on offering a portfolio of products and services for the pharmaceutical industry. By anticipating trends and maintaining a constant dialogue, we provide a first class customer experience.

Sartorius

Photo Gallery from Previous Events

Testimonials

Previous Forums

Keep me updated